These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31702511)

  • 1. Macromolecular Prodrugs Containing Organoiron-Based Compounds in Cancer Research: A Review.
    Mukaya EH; Mbianda XY
    Mini Rev Med Chem; 2020; 20(9):726-738. PubMed ID: 31702511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K; Subr V
    Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug Delivery.
    Kumar S; Sharma B; Bhardwaj TR; Singh RK
    Anticancer Agents Med Chem; 2021; 21(3):383-392. PubMed ID: 32781967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyaspartamides as water-soluble drug carriers. Part 1: Antineoplastic activity of ferrocene-containing polyaspartamide conjugates.
    Swarts JC; Swarts DM; Maree DM; Neuse EW; La Madeleine C; Van Lier JE
    Anticancer Res; 2001; 21(3B):2033-7. PubMed ID: 11497294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular Polymerization-Induced Nanoassemblies for Self-Augmented Cascade Chemotherapy and Chemodynamic Therapy of Tumor.
    Yang K; Yu G; Yang Z; Yue L; Zhang X; Sun C; Wei J; Rao L; Chen X; Wang R
    Angew Chem Int Ed Engl; 2021 Aug; 60(32):17570-17578. PubMed ID: 34041833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-targeted polymeric drugs.
    Luo Y; Prestwich GD
    Curr Cancer Drug Targets; 2002 Sep; 2(3):209-26. PubMed ID: 12188908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer carrier-linked prodrugs in clinical trials.
    Kratz F; Abu Ajaj K; Warnecke A
    Expert Opin Investig Drugs; 2007 Jul; 16(7):1037-58. PubMed ID: 17594188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Conjugates Using Different Dynamic Covalent Bonds and their Application in Cancer Therapy.
    Theodosis-Nobelos P; Charalambous D; Triantis C; Rikkou-Kalourkoti M
    Curr Drug Deliv; 2020; 17(7):542-557. PubMed ID: 32384029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodrug applications for targeted cancer therapy.
    Giang I; Boland EL; Poon GM
    AAPS J; 2014 Sep; 16(5):899-913. PubMed ID: 25004822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy.
    Dragojevic S; Ryu JS; Raucher D
    Molecules; 2015 Dec; 20(12):21750-69. PubMed ID: 26690101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.
    Peng X; Gandhi V
    Ther Deliv; 2012 Jul; 3(7):823-33. PubMed ID: 22900465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anticancer polymeric conjugates of activated nucleoside analogues.
    Senanayake TH; Warren G; Vinogradov SV
    Bioconjug Chem; 2011 Oct; 22(10):1983-93. PubMed ID: 21863885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral benzodiazepine receptor ligand-PLGA polymer conjugates potentially useful as delivery systems of apoptotic agents.
    Laquintana V; Denora N; Musacchio T; Lasorsa M; Latrofa A; Trapani G
    J Control Release; 2009 Aug; 137(3):185-95. PubMed ID: 19374931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
    Peter S; Aderibigbe BA
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in small molecule prodrugs for cancer therapy.
    Wang P; Jin X; Cai J; Chen J; Ji M
    Anticancer Agents Med Chem; 2014 Mar; 14(3):418-39. PubMed ID: 23869777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
    Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
    Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Reshetnikov V; Özkan HG; Daum S; Janko C; Alexiou C; Sauer C; Heinrich MR; Mokhir A
    Molecules; 2020 May; 25(11):. PubMed ID: 32486084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with
    Daum S; Toms J; Reshetnikov V; Özkan HG; Hampel F; Maschauer S; Hakimioun A; Beierlein F; Sellner L; Schmitt M; Prante O; Mokhir A
    Bioconjug Chem; 2019 Apr; 30(4):1077-1086. PubMed ID: 30768258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.